[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 325
Citations 0
Letters
February 13, 2013

Standard-Dose vs High-Dose Multivitamin Supplements for HIV—Reply

Author Affiliations
 

Letters Section Editor: Jody W. Zylke, MD, Senior Editor.

Author Affiliations: Departments of Nutrition (Dr Isanaka; sisanaka@hsph.harvard.edu) and Global Health and Population (Dr Fawzi), Harvard School of Public Health, Boston, Massachusetts; and Department of Internal Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania (Dr Mugusi).

JAMA. 2013;309(6):545-546. doi:10.1001/jama.2012.216995

In Reply: Drs Padayatty and Levine highlight the familiar challenge in selecting doses for trials of multivitamin efficacy and suggest that the null findings in our study of high-dose vs standard-dose multivitamin supplements among patients with HIV initiating antiretroviral therapy may have been due to the location of the selected doses on the average micronutrient dose-response curves. We agree that the micronutrient requirements and metabolism in individuals with HIV are not well understood.

First Page Preview View Large
First page PDF preview
First page PDF preview
×